Nisa Investment Advisors LLC Boosts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Nisa Investment Advisors LLC raised its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 3.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 36,779 shares of the medical instruments supplier’s stock after purchasing an additional 1,242 shares during the quarter. Nisa Investment Advisors LLC’s holdings in DENTSPLY SIRONA were worth $1,309,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Macquarie Group Ltd. raised its holdings in shares of DENTSPLY SIRONA by 3.2% in the 2nd quarter. Macquarie Group Ltd. now owns 8,879 shares of the medical instruments supplier’s stock valued at $318,000 after buying an additional 274 shares during the period. Beach Investment Counsel Inc. PA raised its holdings in shares of DENTSPLY SIRONA by 1.4% in the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock valued at $787,000 after buying an additional 306 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its holdings in shares of DENTSPLY SIRONA by 5.4% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier’s stock valued at $237,000 after buying an additional 359 shares during the period. Kentucky Retirement Systems Insurance Trust Fund raised its holdings in shares of DENTSPLY SIRONA by 4.9% in the 3rd quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 7,721 shares of the medical instruments supplier’s stock valued at $219,000 after buying an additional 360 shares during the period. Finally, VisionPoint Advisory Group LLC raised its holdings in shares of DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 395 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on XRAY. Piper Sandler boosted their price objective on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a report on Friday, January 12th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. SVB Leerink started coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 target price for the company. Needham & Company LLC reissued a “buy” rating and set a $42.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Finally, Barrington Research reissued an “outperform” rating and set a $41.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, March 1st. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $39.50.

Get Our Latest Report on XRAY

DENTSPLY SIRONA Stock Down 2.2 %

NASDAQ:XRAY opened at $31.30 on Monday. The stock has a 50-day simple moving average of $33.08 and a 200-day simple moving average of $32.95. DENTSPLY SIRONA Inc. has a 1 year low of $26.27 and a 1 year high of $43.24. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.55.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. The business had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $972.61 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.46 EPS. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were given a dividend of $0.16 per share. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 2.04%. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio is currently -103.22%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.